Donna Bea-Tillman, the director of the Food & Drug Administration’s office of device evaluation, will apparently resign her post to join the lobbying office of software giant Microsoft Corp., according to a report in the Wall Street Journal.

Tillman, who has been in her position at the Center for Devices and Radiological Health since 1994, notified her colleagues via email March 1, according to the newspaper, which said she will become the director of regulations and policy at the software giant’s health solutions group.

Tillman told colleagues she took the position with Microsoft because of the potential for health information technology to “reduce the skyrocketing cost of health care,” according to a copy of the email obtained by the paper.

“One thing that gives me comfort is the knowledge that you all will continue to do the same great work that you have always done, so that the next time I am in need of a medical device, I can be confident in its safety and effectiveness,” she wrote.